|Disease Group:||Advanced Cancers; Bone; Brain; CNS; Eye; Kidney; Melanoma; Oropharynx; Ovary; Pediatrics; Phase I Studies; Sarcoma; Solid Tumors; Testis|
|Phase of Study:||Phase I|
|Treatment Location:||Both at MDACC & outside MDACC at one or more Collaborating Sites or Institutions|
|Estimated Length of Stay in Houston:||N/A|
|Supported By:||Amgen, Inc.|
|Return Visit:||Cohorts A or D: Weekly; Cohort B: q 2 weeks; Cohort C: q 3 weeks. All cohorts: |
4 weeks after last treatment or more often if clinically necessary.